White Paper
Realizing the value of real-world evidence
Databricks helped biopharma and healthcare organizations realize the value of real-world evidence (RWE) by providing a unified data intelligence platform that integrates and analyzes vast amounts of clinical, claims, and observational data. Their Lakehouse platform supports scalable data processing, advanced analytics, machine learning, and data sharing with Delta Sharing technology. This enables faster drug discovery, improved clinical decision-making, and regulatory compliance, accelerating time to market while reducing trial costs and enhancing patient outcomes through actionable insights.